Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations. / Hughes, D.; Hughes, D.A.; Walley, T.
Yn: Pharmacoeconomics, Cyfrol 19, Rhif 11, 01.01.2001, t. 1069-1077.
Yn: Pharmacoeconomics, Cyfrol 19, Rhif 11, 01.01.2001, t. 1069-1077.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Hughes, DA & Walley, T 2001, 'Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.', Pharmacoeconomics, cyfrol. 19, rhif 11, tt. 1069-1077.
APA
Hughes, D., Hughes, D. A., & Walley, T. (2001). Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations. Pharmacoeconomics, 19(11), 1069-1077.
CBE
Hughes D, Hughes DA, Walley T. 2001. Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations. Pharmacoeconomics. 19(11):1069-1077.
MLA
Hughes, D., D.A. Hughes a T. Walley. "Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.". Pharmacoeconomics. 2001, 19(11). 1069-1077.
VancouverVancouver
Hughes D, Hughes DA, Walley T. Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations. Pharmacoeconomics. 2001 Ion 1;19(11):1069-1077.
Author
RIS
TY - JOUR
T1 - Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Walley, T.
PY - 2001/1/1
Y1 - 2001/1/1
KW - PHARMACOLOGY & PHARMACY
M3 - Article
VL - 19
SP - 1069
EP - 1077
JO - Pharmacoeconomics
JF - Pharmacoeconomics
SN - 1170-7690
IS - 11
ER -